# AN2 Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2023

- Company: [AN2 Therapeutics, Inc.](/companies/antx.md) (CIK 1880438)
- Form: 10-K/A
- Filed: 2024-05-14
- Accepted by EDGAR: May 14, 2024, 20:01 ET
- Period: 2023-12-31
- Accession: 0000950170-24-059488
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1880438/000095017024059488/antx-20231231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1880438/000095017024059488/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1880438/000095017024059488/antx-20231231.htm

Filed May 14, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-059488. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.